Changes in alcohol consumption after treatment for depression: a secondary analysis of the Swedish randomised controlled study REGASSA.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 11 2019
Historique:
entrez: 13 11 2019
pubmed: 13 11 2019
medline: 31 10 2020
Statut: epublish

Résumé

Mental health problems and hazardous alcohol consumption often co-exist. Hazardous drinking could have a negative impact on different aspects of health and also negatively influence the effect of mental health treatment. The aims of this study were to examine if alcohol consumption patterns changed after treatment for depression and if the changes differed by treatment arm and patient sex. This study of 540 participants was conducted in a large randomised controlled trial (RCT) that aimed to compare the effect of internet-based cognitive behavioural therapy, physical exercise and treatment as usual on 945 participants with mild-to-moderate depression. Treatment lasted for 12 weeks; alcohol consumption (Alcohol Use Disorder Identification Test (AUDIT)) and depression (Montgomery Åsberg Depression Rating Scale (MADRS)) were assessed at baseline and 12-month follow-up. Changes in alcohol consumption were examined in relation to depression severity, treatment arm and patient sex. The AUDIT distribution for the entire group remained unchanged after treatment for depression. Hazardous drinkers exhibit decreases in AUDIT scores, although they remained hazardous drinkers according to the cut-off scores. Hazardous drinkers experienced similar improvements in symptoms of depression compared with non-hazardous drinkers, and there was no significant relation between changes in AUDIT score and changes in depression. No differences between treatment arm and patient sex were found. The alcohol consumption did not change, despite treatment effects on depression. Patients with depression should be screened for hazardous drinking habits and offered evidence-based treatment for hazardous alcohol use where this is indicated. DRKS00008745.

Identifiants

pubmed: 31712330
pii: bmjopen-2018-028236
doi: 10.1136/bmjopen-2018-028236
pmc: PMC6858246
doi:

Banques de données

DRKS
['DRKS00008745']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e028236

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
J Affect Disord. 2002 Nov;72(2):177-84
pubmed: 12200208
Alcohol Alcohol. 2002 May-Jun;37(3):245-51
pubmed: 12003912
Drug Alcohol Depend. 2008 May 1;95(1-2):62-72
pubmed: 18243584
Alcohol Alcohol. 2016 Nov;51(6):655-663
pubmed: 26956426
Aust N Z J Psychiatry. 2018 Aug;52(8):737-750
pubmed: 29466868
Alcohol Clin Exp Res. 2007 Jul;31(7):1208-17
pubmed: 17451397
J Affect Disord. 2003 Dec;77(3):255-60
pubmed: 14612225
Int J Methods Psychiatr Res. 2013 Sep;22(3):175-84
pubmed: 24038301
J Subst Abuse Treat. 2014 Mar;46(3):281-90
pubmed: 24210534
BMC Public Health. 2015 Jun 09;15:542
pubmed: 26051511
Br J Psychiatry. 1986 May;148:599-601
pubmed: 3779233
Br J Psychiatry. 2015 Sep;207(3):227-34
pubmed: 26089305
Acta Psychiatr Scand. 2012 Dec;126(6):434-9
pubmed: 22533852
J Affect Disord. 2016 Dec;206:169-173
pubmed: 27475887
J Affect Disord. 2012 Aug;139(3):217-29
pubmed: 21890213
Neuropsychobiology. 2004;50(1):57-64
pubmed: 15179022
Prev Med. 2015 Jul;76 Suppl:S33-8
pubmed: 25514547
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Cochrane Database Syst Rev. 2018 Feb 24;2:CD004148
pubmed: 29476653
Br J Psychiatry. 2016 Nov;209(5):414-420
pubmed: 27609813
BMJ Open. 2018 Mar 6;8(3):e019128
pubmed: 29511011
Alcohol Clin Exp Res. 2015 Jan;39(1):158-65
pubmed: 25623414
BJPsych Open. 2018 Jul 16;4(4):265-273
pubmed: 30057780
Am J Addict. 2014 Nov-Dec;23(6):570-5
pubmed: 25164533
Am J Med. 2005 Apr;118(4):330-41
pubmed: 15808128
Addiction. 2011 May;106(5):906-14
pubmed: 21382111
PLoS One. 2012;7(5):e36905
pubmed: 22615841
Addiction. 2014 Mar;109(3):394-406
pubmed: 24304463
Soc Psychiatry Psychiatr Epidemiol. 2009 Dec;44(12):1013-21
pubmed: 19294323
Health Policy. 2001 Jan;55(1):51-69
pubmed: 11137188
Addict Behav. 2008 Feb;33(2):301-14
pubmed: 18029104
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Br J Clin Psychol. 2016 Nov;55(4):414-428
pubmed: 27059176
PLoS One. 2014 Aug 14;9(8):e104615
pubmed: 25122509
J Affect Disord. 2009 Dec;119(1-3):52-8
pubmed: 19361865
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889
JAMA. 2003 Jun 18;289(23):3095-105
pubmed: 12813115

Auteurs

Catharina Strid (C)

Department of Psychology, Lund University, Lund, Sweden catharina.strid@psy.lu.se.

Mats Hallgren (M)

Department of Public Health Science, Section of Epidemiology and Public Health Intervention Research, Karolinska Institutet, Stockholm, Sweden.

Yvonne Forsell (Y)

Department of Public Health Science, Section of Epidemiology and Public Health Intervention Research, Karolinska Institutet, Stockholm, Sweden.

Martin Kraepelien (M)

Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden.

Agneta Öjehagen (A)

Department of Clinical Science, Lund, Division of Psychiatry, Lund University, Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH